Alan, which offers personalized mental health programs through its app, raises a €183M Series E led by Canadian Teachers Venture Growth at a €2.7B valuation
Alan, unlike many other big healthtech startups in Europe like Kry/Livi and Ada Health, has companies as its customers.
Context & Ripple Effects
Alan's raise is the third leg of a steep valuation climb: a €185M round led by Coatue at a €1.4B valuation in April 2021, then this €183M Series E at €2.7B just a year later — a doubling that Canadian Teachers Venture Growth, a pension-fund investor, is underwriting. The differentiator Sifted flags is distribution: unlike consumer-facing European healthtech peers Kry/Livi and Ada Health, Alan sells to companies, which buy the app and its mental health programs for employees.
The corpus shows the bet paying out on the trajectory that follows: Alan later raises €173M led by Belfius Bank at €4B, then a €100M round at €5B, and ultimately a €480M Prosus-led round at €5.5B with €1B+ in ARR — making this Series E the midpoint of a run that kept it a unicorn even as roughly 30% of European unicorns reportedly lost billion-dollar status.
First-order effects
- Alan's valuation doubles from €1.4B to €2.7B in twelve months, giving it fresh capital to scale the employer-sold model across France, Belgium and Spain where it already serves 155K members.
Second-order effects
- Rivals Kry/Livi and Ada Health, which sell to individual consumers, now face a competitor whose company customers provide built-in distribution and lower acquisition costs — pressure to add B2B channels of their own.
Third-order effects
- Pension-fund capital like Canadian Teachers' flowing into European healthtech signals institutional investors treating employer-distributed health insurance as an infrastructure-grade asset class, not venture lottery tickets — a channel shift that could restructure how health coverage is sold in Europe.
The trend: European healthtech is consolidating around B2B distribution, with employer-sold platforms like Alan commanding successive valuation doublings while consumer-first peers compete for individual users.